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Age < 65 Age> 65
Patients Controls Patients Controls
Homocysteine 12.2 ± 4.0' 11.0 ± 3.4 14.2 ± 4.6' 11.9 ± 3.6
High HCY(%) 33' 20 50t 25
Odds Ratios 2.0' NA 2.9' NA
Confidence Interval 12-3.2 NA lQ-8.3 NA
Ciradian Variation of Silent Myocardial Ischemia
is Abolished by Propranolol
Relationship Between Homocyst(e)ine, Vitamin
B12 and Cardiac Disease in the Elderly
Barry C. Herzlich, Martin Weinstock, Edgar Lichstein, Nancy Schulhoff, M.
Rene Malinow. Maimonides Medical Center, State University of New York Health
Science Center at Brooklyn, NY; Oregon Regional Primate Research Center, Beaverton,
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Elevated plasma homocyst(e)ine (HCS) is an independent risk factor for coro-
nary artery disease (CAD) among middle aged adults. Moveover, HCS also in-
creases with age. This study assessed plasma HCS among 384 elderly (ages
73 ± 7 y) patients undergoing coronary angiography. The degree of CAD was
scored using proximal and diffuse (Freisenger) indices. Plasma HCS, serum
Vitamin B12 and folate and left ventricular ejection fraction (LVEF) were mea-
sured and risk factors for CAD were recorded. There was no apparent corre-
lation between plasma HCS and extent of CAD after adjusting for age. Nine
percent of patients (pts) had Vitamin B12 deficiency (B12 def), ie. Vitamin
B12. < 300 pg/ml as well as HCS > 16 nmol/ml. LVEF for the 32 B12 def
pts ~ 40.5% was significantly less than for 326 non B12 def pts with LVEF
= 50.6% (p < 0.001). Significance remained after adjusting for proximal and
Freisenger indices, history of smoking, diabetes, previous myocardial infarc-
tion, age and sex. (Adjusted Difference of LVEF ~ 8.2, 95% CI 2.6-13.8).
In conclusion we did not find a significant correlation between plasma HCS
and extent of CAD as assessed angiographically using proximal and diffuse
indices. The data demonstrate that B12 def pts (with elevated HCS levels)
had significantly lower LVEF than non B12 def pts. Whether low LVEF results
in malabsorption of Vitamin B12 and B12 def or, conversely, whether B12
def and its marker, ie, elevated HCS, depress LVEF, warrants further investi-
gation.
Wilbert S. Aronow, Chul Ahn, Anthony D. Mercando, Stanley Epstein. Hebrew
Hospital Home and Mount Sinai School ofMedicine, New York, NY
A prospective study investigated whether there is a circadian variation of
silent ischemia (SI) in elderly patients (pts) with heart disease before and after
propranolol and no antiarrhythmic (AA) drug. Follow-up 24-hour ambulatory
electrocardiograms were obtained at a median of 6 months (range 2 to 12)
in 221 elderly pts, mean age 81 ± 8 years, with heart disease (64% with prior
myocardial infarction and 36% with hypertensive heart disease) and complex
ventricular arrhythmias randomized to propranolol 85 ± 28 mg daily(112 pts)
or to no AA drug (109 ptsj. SI was diagnosed if horizontal or downsloping ST-
segment depression::: 1.0 mm below the level at rest occurred after the J
point, lasted::: 1.0 minute, and was unassociated with angina. If ST-segment
depression at rest occurred, an additional 2.0 mm of ischemic ST-segment
depression below the level at rest at 80 ms after the J point was needed. 51
was present before no AA drug in 35 of 109 pts (32%) and after no AA drug
in 39 of 109 pts (36%1 (p not significant). SI was present before propranolol
in 42 of 112 pts (38%) and after propranolol in 27 of 112 pts (24%) (p <
0.001). Double harmonic regression models showed a significant circadian
variation of the maximal amount of 51 before no AA drug (p = 0.002, R2 ~
58%, adjusted R2 = 49%). after no AA drug (p = 0.009, R2 = 50%, adjusted
R2 = 39%), before propranolol (p = 0.003, R2 = 56%, adjusted R2 = 46%1.
Methods: We studied 228 patients with angiographically documented
coronary disease (:::70% stenosis in at least one major epicardial vessel).
These included 136 patients less than, and 92 greater than 65 years old. Pa-
tients were compared to 223 healthy controls 199 «65) and 24 (>65). The
presence of traditional risk factors including hypertension, smoking, hyper-
cholesterolemia and diabetes mellitus were noted. Total fasting plasma ho-
mocysteine was measured in all subjects. A gender-adjusted threshold for a
high homocysteine level was defined as the 80th percentile for healthy con-
trols (corresponding to a level of 11.7 IlmollL in women and 13.61lmo1lL in
men).
Results:
'p< am vs controls, t p < 0.03
Conclusions: Homocysteine concentrations are elevated in patients with
coronary artery disease older than 65 years in age. A high value confers an in-
dependent three-fold risk for coronary disease in this patient group. Accord-
ingly, intervention studies designed to reduce plasma homocysteine levels
should not exclude the elderly.
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Lower Adenosine Levels During Early Ischemia:
Cause of Increased Injury in the Aging Heart?
Kishin Ramani, W. David Lust. Tim S. Whittingham, Edward J. Lesnefsky. Case
Western Reserve University. Cleveland, OH
Pre- Ischemia
ischemia 2 min 5min 10min 15 min 25 min
(n = 5) In ~ 51 tn = 6) (n = 6) (n ~ 5) tn ~ 5)
ADO 6mo 0.2 ± 0.1 0.7 ± 0.1 0.7 ± 0.1 2.2 ± 0.2 37 ± 0.6 4.5 ± 0.3
24 mo 0.2 ± 0.1 05 ± 0.1 0.3 ± 0.1' 1.1 ± 0.3' 2.1 ± 0.3' 3.5 ± 04
HX 6mo 2.0 ± 0.2 1.6 ± 0.2 2.3 ± 03 2.2 ± 01 25 ± 0.2 2.8 ± 02
24mo 1.9 ± 0.2 1.4 ± 0.1 1.4 ± 02' 2.1 ± 0.2 2.2 ± 0.8 3.5 ± 03
(Mean ± SE, nmol/mg protein). 'p < 0.05 vs 6 mo
Myocardial injury following ischemia and reperfusion is increased in the ag-
ing heart, including in the aging 24 mo Fischer 344 rat (mean survival 29 mol
compared to the Fischer 344 adult (6 mo). Adenosine (ADO) has been in-
creasingly appreciated as a cardioprotective agent in myocardial ischemia.
We hypothesized that a potential mechanism of the increased injury in the
aging heart is decreased production of ADO in response to ischemia. Iso-
lated buffer perfused (glucose 5 mM - insulin 5 Ilfl) hearts from aging and
adult Fischer 344 rats were subjected to stop-flow ischemia for either 2, 5,
10, 15 or 25 min after a 15 min equilibration phase. ADO and hypoxanthine
(HX) were measured by HPLC Tissue total adenylates, ATP. glycogen and
lactate were measured.
available regarding the prognostic importance of SI in the elderly. Therefore,
we prospectively evaluated the prognostic significance of SI during Holter
monitoring (HM) in elderly pts (:::65 years) with stable angina and proved
CAD. The findings were then compared to those observed in a similar but
younger «65 yrs age) group of pts with stable CAD. All pts underwent max-
imal exercise treadmill test (ED) and HM for 24--48 hours, while receiving
their usual antianginal drugs. Pts were followed every 3 months and all fatal
and nonfatal events were recorded. The study population consisted of two
groups: pts < 65 (Gr 11 and pts ::: 65 (Gr 2) years old. The two groups were
similar in their clinical characteristics, risk factors for CAD, antianginal drugs,
and angiographic findings. Compared to Gr 1, the Gr 2 pts had a significantly
earlier onset of ischemia (p < 0.01) and achieved a significantly greater peak
systolic blood pressure (p < 0.02) during ED. Kaplan-Meier survival analy-
sis revealed a significant difference in the outcome of the two groups. The
Gr 1 pts with SI during HM had a nonsignificant increase in mortality (2/16,
12.5% vs. 1/19, 5.3%) compared to pts without SI. In contrast, elderly (Gr
2) pts with SI during HM had an eightfold increase in the risk of cardiac
death (7/23, 30.4% mortality vs. 1/28,3.6%, P = 0.009) compared to elderly
pts without SI. Multivariate Cox regression analysis of clinical variables, an-
giographic findings, ED parameters, and ischemia during HM, revealed the
presence of SI on HM as the most powerful and independent predictor (p ~
0.006) of cardiac death in the elderly.
Conclusion: The findings of our study clearly demonstrated that in the el-
derly pts, silent ischemia during daily life is associated with poor progno-
sis and a significantly increased risk of cardiac death. The adverse outcome
associated with SI was noted despite antianginal drug therapy effective in
controlling symptoms suggesting the need for more aggressive therapeutic
interventions.
ADO levels were 50% lower in the aging heart at 5 and 10 min, remained
depressed at 15 min and had not fully equalized to adult levels by 25 min
of ischemia. HX was decreased at 5 min, consistent with decreased ADO
production at that time. The change in total adenylate pool was similar in
both groups. The decrease in tissue glycogen and increase in lactate were
similar during ischemia in both groups, suggesting comparable glycolytic
activity. ATP levels were decreased in aging hearts at 5 min (11.1 ± 2.3 vs
18.7 ± 1.9 nmol/mg protein). but reached levels similar to adult hearts as
ischemia progressed.
Thus, decreased ADO levels during early ischemia may reflect reduced
production of ADO in the aging heart, and increase the susceptibility of the
aging heart to damage during ischemia and reperfusion.
Background: High plasma homocysteine (HCYj concentration is an estab-
lished risk factor for premature vascular disease which can be reduced using
vitamin therapy. The role of increased homocysteine as a coronary risk factor
in the elderly, however, remains uncertain.
Elevated Plasma Homocysteine: An Important
Independent Risk Factor for Coronary Artery
Disease in the Elderly
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